Biora Therapeutics Inc
NASDAQ:BIOR
Biora Therapeutics Inc
NASDAQ:BIOR
Price:
0.22
USD
Market Closed
Market Cap:
$994.4k
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Biora Therapeutics Inc
NASDAQ:BIOR
|
US |
|
V
|
Vicem But Son Cement JSC
VN:BTS
|
VN |
|
Yageo Corp
TWSE:2327
|
TW |
|
Gruma SAB de CV
BMV:GRUMAB
|
MX |
|
Asahi Kasei Corp
TSE:3407
|
JP |
|
V
|
Vishnu Prakash R Punglia Ltd
NSE:VPRPL
|
IN |
|
Eisai Co Ltd
TSE:4523
|
JP |
|
J
|
Jyske Bank A/S
LSE:0MGD
|
DK |
|
Finolex Industries Ltd
NSE:FINPIPE
|
IN |
|
Good Drinks Australia Ltd
ASX:GDA
|
AU |
|
Auplata Mining Group SA
PAR:ALAMG
|
GF |
|
Sunjin Co Ltd
KRX:136490
|
KR |
|
C
|
Cybozu Inc
TSE:4776
|
JP |
|
Shenzhen Energy Group Co Ltd
SZSE:000027
|
CN |
|
St Augustine Gold and Copper Ltd
TSX:SAU
|
SG |
|
S
|
SKF India Ltd
BSE:500472
|
IN |
|
Acreage Holdings Inc
OTC:ACRDF
|
US |
|
Black Stone Minerals LP
NYSE:BSM
|
US |
|
Sindoh Co Ltd
KRX:029530
|
KR |
|
DCM Ltd
NSE:DCM
|
IN |
|
S
|
Sovereign Metals Ltd
LSE:SVML
|
AU |
|
Nihon Dempa Kogyo Co Ltd
TSE:6779
|
JP |
|
S
|
Seko SA
WSE:SEK
|
PL |
|
FDM Group (Holdings) PLC
LSE:FDM
|
UK |
Balance Sheet
Balance Sheet Decomposition
Biora Therapeutics Inc
Biora Therapeutics Inc
Balance Sheet Decomposition is not available for
Biora Therapeutics Inc
Biora Therapeutics Inc
Balance Sheet
Biora Therapeutics Inc
Biora Therapeutics Inc
Currency: USD
| Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Cash Equivalents |
49
|
33
|
92
|
88
|
31
|
15
|
|
| Cash Equivalents |
49
|
33
|
92
|
88
|
31
|
15
|
|
| Short-Term Investments |
20
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
8
|
23
|
7
|
1
|
1
|
1
|
|
| Accounts Receivables |
2
|
22
|
7
|
1
|
0
|
0
|
|
| Other Receivables |
6
|
1
|
0
|
0
|
1
|
0
|
|
| Inventory |
8
|
11
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
4
|
8
|
28
|
10
|
7
|
3
|
|
| Total Current Assets |
89
|
75
|
126
|
99
|
38
|
19
|
|
| PP&E Net |
15
|
16
|
8
|
4
|
3
|
3
|
|
| PP&E Gross |
15
|
16
|
8
|
4
|
3
|
3
|
|
| Accumulated Depreciation |
14
|
17
|
6
|
6
|
4
|
2
|
|
| Intangible Assets |
6
|
5
|
0
|
0
|
0
|
0
|
|
| Goodwill |
6
|
6
|
6
|
6
|
6
|
6
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
6
|
3
|
|
| Other Long-Term Assets |
0
|
0
|
14
|
0
|
0
|
0
|
|
| Other Assets |
6
|
6
|
6
|
6
|
6
|
6
|
|
| Total Assets |
116
N/A
|
102
-13%
|
154
+52%
|
109
-30%
|
54
-51%
|
31
-42%
|
|
| Liabilities | |||||||
| Accounts Payable |
11
|
16
|
17
|
9
|
4
|
3
|
|
| Accrued Liabilities |
61
|
78
|
50
|
31
|
14
|
15
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1
|
1
|
0
|
0
|
0
|
2
|
|
| Other Current Liabilities |
5
|
6
|
5
|
22
|
6
|
44
|
|
| Total Current Liabilities |
78
|
100
|
73
|
62
|
23
|
63
|
|
| Long-Term Debt |
72
|
72
|
160
|
126
|
128
|
44
|
|
| Other Liabilities |
4
|
13
|
29
|
6
|
5
|
26
|
|
| Total Liabilities |
153
N/A
|
186
+21%
|
261
+41%
|
194
-26%
|
156
-20%
|
133
-15%
|
|
| Equity | |||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
143
|
349
|
541
|
789
|
827
|
951
|
|
| Additional Paid In Capital |
124
|
283
|
453
|
723
|
744
|
869
|
|
| Treasury Stock |
19
|
19
|
19
|
19
|
19
|
19
|
|
| Total Equity |
37
N/A
|
84
-127%
|
107
-28%
|
85
+21%
|
102
-20%
|
101
+1%
|
|
| Total Liabilities & Equity |
116
N/A
|
102
-13%
|
154
+52%
|
109
-30%
|
54
-51%
|
31
-42%
|
|
| Shares Outstanding | |||||||
| Common Shares Outstanding |
2
|
2
|
2
|
7
|
9
|
3
|
|
Switch to:
Switch to:
See Also
Discover More
